FDA Scrutiny Looms For Unapproved Research Tests
The U.S. Food and Drug Administration on Monday edged away from controversial plans to force manufacturers of unapproved diagnostic tests sold for research purposes to ensure that their customers don't use...To view the full article, register now.
Already a subscriber? Click here to view full article